Advertisement

Vitiligo pp 79-90 | Cite as

Autoimmune/Inflammatory and Other Diseases Associated with Vitiligo

  • Ilse MolletEmail author
  • Nanny van Geel
  • Jo Lambert

Core Messages

  • Although the exact aetiology of vitiligo remains unclear, vitiligo is widely considered to have an autoimmune component in its pathogenesis based on disease associations.

  • According to ethnic background, large variations exist in association with autoinflamma-tory/autoimmune disorders.

  • Some reported associations may reflect a simple coexistence of two disorders, and the repertoire of associations may help to detect shared heritable predispositions for inflamma-tion and autoimmunity.

  • Thyroid disorders are the most commonly associated to vitiligo in Caucasian populations, alopecia areata in Chinese populations, rheumatoid arthritis (RA) being more rarely associated in both.

Keywords

Pernicious Anaemia Lichen Planus Autoimmune Thyroiditis Autoimmune Thyroid Disease Alopecia Areata 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Notes

Acknowledgments

I.M. is supported by grant G.0161.07 of the Research Foundation Flanders.

References

  1. 1.
    Ahmed I, Nasreen S, Bhatti R (2007) Alopecia Areata in Children. J Coll Physicians Surg Pak 17:587–590PubMedGoogle Scholar
  2. 2.
    Alkhateeb A, Fain PR, Thody A, Bennett DC et al (2003) Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their families. Pigment Cell Res 16:208–214PubMedCrossRefGoogle Scholar
  3. 3.
    Amerio P, Tracanna M, De Remigis P et al (2006) Vitiligo associated with other autoimmune diseases: polyglandular autoimmune syndrome types 3B + C and 4. Clin Exp Dermatol 31:746–749PubMedCrossRefGoogle Scholar
  4. 4.
    Anstey A, Marks R (1993) Colocalization of lichen planus and vitiligo. Br J Dermatol 128:103–104PubMedCrossRefGoogle Scholar
  5. 5.
    Antony FC, Marsden RA (2003) Vitiligo in association with human immunodeficiency virus infection. J Eur Acad Dermatol Venereol 20:63–65Google Scholar
  6. 6.
    Baran R, Ortonne JP, Perrin C (1997) Vitiligo associated with a lichen planus border. Dermatology 194:199PubMedCrossRefGoogle Scholar
  7. 7.
    Barnadas MA, Rodriguez-Arias JM, Alomar A (2000) Subcutaneous sarcoidosis associated with vitiligo, pernicious anaemia and autoimmune thyroiditis. Clin Exp Dermatol 25:55–56PubMedCrossRefGoogle Scholar
  8. 8.
    Berd D, Mastrangelo MJ, Lattime E et al (1996) Melanoma and vitiligo: immunology's Grecian urn. Cancer Immunol Immunother 42:263–267PubMedCrossRefGoogle Scholar
  9. 9.
    Betterle C, Greggio NA, Volpato M (1998) Clinical review: autoimmune polyglandular disease type 1. J Clin Endocrinol Metab 83:1049–1055PubMedCrossRefGoogle Scholar
  10. 10.
    Betterle C, Zanchetta R (2003) Update on autoimmune poly-endocrine syndromes (APS). Acta Bio Med 74:9–33Google Scholar
  11. 11.
    Birlea SA, Fain PR, Spritz RA (2008) A Romanian population isolate with high frequency of vitiligo and associated autoimmune diseases. Arch Dermatol 144:310–316PubMedCrossRefGoogle Scholar
  12. 12.
    Bonifati G, Impara G, Morrone A et al (2006) Simultaneous occurrence of linear scleroderma and homolateral segmental vitiligo. J Eur Acad Dermatol Venereol 20:63–65PubMedCrossRefGoogle Scholar
  13. 13.
    Braverman IM (2003) Sarcoidosis. In: Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI (eds) Fitzpatrick's dermatology in general medicine. McGraw-Hill, New YorkGoogle Scholar
  14. 14.
    Bystryn JC, Rigel D, Friedman RJ et al (1997) Prognostic significance of hypopigmentation in malignant melanoma. Arch Dermatol 123:1053–1056CrossRefGoogle Scholar
  15. 15.
    Cavallari V, Cannavo SP, Ussia AF (1996) Vitiligo associated with metastatic malignant melanoma. Int J Dermatol 35:738–740PubMedCrossRefGoogle Scholar
  16. 16.
    Christophers E, Mrowietz U (2003) Psoriasis. In: Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI (eds) Fitzpatrick's dermatology in general medicine. McGraw-Hill, New YorkGoogle Scholar
  17. 17.
    Costner MI, Sontheimer RD (2003) Lupus erythematosus. In: Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI (eds) Fitzpatrick's dermatology in general medicine. McGraw-Hill, New YorkGoogle Scholar
  18. 18.
    Cruz MW, Maranhao Filho PA, André C et al (1994) Myasthenia gravis and vitiligo. Muscle Nerve 17:559–560PubMedCrossRefGoogle Scholar
  19. 19.
    Cunliffe WJ, Hall R, Newell DJ et al (1968) Vitiligo, thyroid disease and autoimmunity. Br J Dermatol 80:135–139PubMedCrossRefGoogle Scholar
  20. 20.
    Damico FM, Kiss S, Young LH (2005) Vogt-Koyanagi-Harada disease. Semin Ophthalmol 20:183–190PubMedCrossRefGoogle Scholar
  21. 21.
    Daoud MS, Pittelkow MR (2003) Lichen planus. In: Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI (eds) Fitzpatrick's dermatology in general medicine. McGraw-Hill, New YorkGoogle Scholar
  22. 22.
    Dawber RPR (1968) Vitiligo in mature-onset diabetes mel-litus. Br J Dermatol 20:275–278CrossRefGoogle Scholar
  23. 23.
    Dawber RPR (1970) Integumentary associations of pernicious anemia. Br J Dermatol 82:221–223PubMedCrossRefGoogle Scholar
  24. 24.
    Demirkök SS, Arzuhal N, Devranoglu G et al (2007) Recurrent sarcoidosis on a scar associated with vitiligo. J Dermatol 34:829–833PubMedCrossRefGoogle Scholar
  25. 25.
    Dhar S, Malakar S, Dhar S (1998) Colocalization of vitiligo and psoriasis in a 9-year-old boy. Pediatr Dermatol 15:242–243CrossRefGoogle Scholar
  26. 26.
    Dienstag JL (2008) Chronic hepatitis. In: Fauci AS, Braunwald E, Kasper DL, Hauser SL, Longo DL, Jameson L, Loscalzo J (eds) Harrison's principles of internal medicine. McGraw-Hill, New YorkGoogle Scholar
  27. 27.
    DiGiovanna JJ (2003) Ichthyosiform dermatoses. In: Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI (eds) Fitzpatrick's dermatology in general medicine. McGraw-Hill, New YorkGoogle Scholar
  28. 28.
    Dogra S, Parsad D, Handa S et al (2005) Late-onset vitiligo: a study of 182 patients. Int J Dermatol 44:193–196PubMedCrossRefGoogle Scholar
  29. 29.
    Drachman DB (2008) Myasthenia gravis and other diseases of the neuromuscular junction. In: Fauci AS, Braunwald E, Kasper DL, Hauser SL, Longo DL, Jameson L, Loscalzo J (eds) Harrison's principles of internal medicine. McGraw-Hill, New YorkGoogle Scholar
  30. 30.
    Duvic M, Rapini R, Hoots WK et al (1987) Human immuno-deficiency virus-associated vitiligo: expression of autoim-munity with immunodeficiency? J Am Acad Dermatol 17:656–662PubMedCrossRefGoogle Scholar
  31. 31.
    Eisenbarth GS, Gottlieb PA (2003) The immunoendocrinop-athy syndromes. In: Larsen PR, Kronenberg HM, Melmed S, Polonsky KS (eds) Williams textbook of endocrinology. Saunders, PhiladelphiaGoogle Scholar
  32. 32.
    Eisenbarth GS, Polonsky KS, Buse JB (2003) Type 1 diabetes mellitus. In: Larsen PR, Kronenberg HM, Melmed S, Polonsky KS (eds) Williams textbook of endocrinology. Saunders, PhiladelphiaGoogle Scholar
  33. 33.
    Fauci AS, Lane HC (2008) Human immunodeficiency virus disease: AIDS and related disorders. In: Fauci AS, Braunwald E, Kasper DL, Hauser SL, Longo DL, Jameson L, Loscalzo J (eds) Harrison's principles of internal medicine. McGraw-Hill, New YorkGoogle Scholar
  34. 34.
    Finkelstein E, Amichai B, Metzker A (1995) Coexistence of vitiligo and morphea: a case report and review of the literature. J Dermatol 22:351–353PubMedGoogle Scholar
  35. 35.
    Freyschmidt-Paul P, McElwee K, Hoffman R (2005) Alopecia Areata. In: Hertl M (ed) Autoimmune diseases of the skin. Springer, New YorkGoogle Scholar
  36. 36.
    Friedman S, Blumberg RS (2008) Inflammatory bowel disease. In: Fauci AS, Braunwald E, Kasper DL, Hauser SL, Longo DL, Jameson L, Loscalzo J (eds) Harrison's principles of internal medicine. McGraw-Hill, New YorkGoogle Scholar
  37. 37.
    Gogas H, Ioannovich J, Dafni U et al (2006) Prognostic sig-nificance of autoimmunity during treatment of melanoma with interferon. N Engl J Med 354:709–718PubMedCrossRefGoogle Scholar
  38. 38.
    Gould IM, Gray RS, Urbaniak SJ et al (1985) Vitiligo in diabetes mellitus. Br J Dermatol 113:153–155PubMedCrossRefGoogle Scholar
  39. 39.
    Grunnet I, Howitz J (1970) Vitiligo and pernicious anemia. Arch Dermatol 101:82–85PubMedCrossRefGoogle Scholar
  40. 40.
    Guarnieri F, Aragona P, Vaccaro M (2004) Vogt-Koyanagi-Harada syndrome. In: Lotti T, Hercogovà J (eds) Vitiligo problems and solutions. Marcel Dekker, New YorkGoogle Scholar
  41. 41.
    Gül Ü, Kiliç A, Tulunay Ö et al (2007) Vitligo associated with malignant melanoma and lupus erythematosus. J Dermatol 34:142–145PubMedCrossRefGoogle Scholar
  42. 42.
    Hahn BH (2008) Systemic lupus erythematosus. In: Fauci AS, Braunwald E, Kasper DL, Hauser SL, Longo DL, Jameson L, Loscalzo J (eds) Harrison's principles of internal medicine. McGraw-Hill, New YorkGoogle Scholar
  43. 43.
    Harris M (2000) Definition and classification of diabetes mellitus and the new criteria for diagnosis. In: LeRoith D, Taylor SI, Olefsky JM Diabetes mellitus. Lippincott Williams & Wilkins, PhiladelphiaGoogle Scholar
  44. 44.
    Hauser SL, Goodin DS (2008) Multiple sclerosis and other demyelinating diseases. In: Fauci AS, Braunwald E, Kasper DL, Hauser SL, Longo DL, Jameson L, Loscalzo J (eds) Harrison's principles of internal medicine. McGraw-Hill, New YorkGoogle Scholar
  45. 45.
    Hollar CB, Jorizzo JL (2003) Rheumatoid arthritis. In: Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI (eds) Fitzpatrick's dermatology in general medicine. McGraw-Hill, New YorkGoogle Scholar
  46. 46.
    Huggins RH, Janusz CA, Schwartz RA (2006). Vitiligo: a sign of systemic disease. Indian J Dermatol Venereol Leprol 72:68–71PubMedCrossRefGoogle Scholar
  47. 47.
    Jabbour SA (2003) Cutaneous manifestations of endocrine disorders. Am J Clin Dermatol 4:315–331PubMedCrossRefGoogle Scholar
  48. 48.
    Jameson JL, Weetman AP (2008) Disorders of the thyroid gland. In: Fauci AS, Braunwald E, Kasper DL, Hauser SL, Longo DL, Jameson L, Loscalzo J (eds) Harrison's principles of internal medicine. McGraw-Hill, New YorkGoogle Scholar
  49. 49.
    Klisnick A, Schmidt J, Dupond JL et al (1998) Le vitiligo au cours des syndromes auto-immuns multiples: étude retrospective de 11 observations et revue de la litérature. Rev Méd Interne 19:348–352PubMedCrossRefGoogle Scholar
  50. 50.
    Kovacs OS (1998) Vitiligo. J Am Acad Dermatol 38:647–648PubMedCrossRefGoogle Scholar
  51. 51.
    Kubota A, Komiyama A, Tanigawa A et al (1997) Frequency and clinical correlates of vitiligo in myasthenia gravis. J Neurol 244:388–401PubMedCrossRefGoogle Scholar
  52. 52.
    Laberge G, Mailloux CM, Gowan K et al (2005) Early disease onset and increased risk of other autoimmune diseases in familial generalized vitiligo. Pigment Cell Res 18:300–305PubMedCrossRefGoogle Scholar
  53. 53.
    Langley RGB, Barnhill RL, Mihm MC Jr et al (2003) Neoplasms: cutnaeous melanoma. In: Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI (eds) Fitzpatrick's dermatology in general medicine. McGraw-Hill, New YorkGoogle Scholar
  54. 54.
    Lerner AB (1959) Vitiligo. J Invest Dermatol 32:285–310PubMedCrossRefGoogle Scholar
  55. 55.
    Lipsky PE (2008) Rheumatoid arthritis. In: Fauci AS, Braunwald E, Kasper DL, Hauser SL, Longo DL, Jameson L, Loscalzo J (eds) Harrison's principles of internal medicine. McGraw-Hill, New YorkGoogle Scholar
  56. 56.
    Liu JB, Li M, Yang S et al (2005) Clinical profiles of vitiligo in China: an analysis of 3742 patients. Clin Exp Dermatol 30:327–331PubMedCrossRefGoogle Scholar
  57. 57.
    Marzano AV, Gasparini LG, Cavicchini S et al (1996) Scar sarcoidosis associated with vitiligo, autoimmune thyroiditis and autoimmune chronic hepatitis. Clin Exp Dermatol 21:466–467PubMedCrossRefGoogle Scholar
  58. 58.
    Masharani U, German MS (2007) Pancreatic hormones & diabetes mellitus. In: Gardner DG, Shoback D (eds) Basic and clinical endocrinology. McGraw-Hill, New YorkGoogle Scholar
  59. 59.
    Neufeld M, Maclaren N, Blizzard R (1980) Autoimmune polyglandular syndromes. Pediatr Ann 9:154–162PubMedGoogle Scholar
  60. 60.
    Nickoloff BJ, Qin JZ, Nestle FO (2007) Immunopathogenesis of psoriasis. Clin Rev Allerg Immunol 33:45–56CrossRefGoogle Scholar
  61. 61.
    Nordlund JJ, Hann S-K (2000) The association of vitiligo with disorders of other organ systems. In: Hann S-K, Nordlund JJ (eds) Vitiligo. Blackwell Science. OxfordGoogle Scholar
  62. 62.
    Nordlund JJ, Kirkwood JM, Forget BM et al (1983) Vitiligo in patients with metastatic melanoma: a good prognostic sign. J Am Acad Dermatol 9:689–691PubMedCrossRefGoogle Scholar
  63. 63.
    Noseworthy JH, Luchinetti C, Rodriguez M et al (2000) Multiple sclerosis. N Engl J Med 343:938–952PubMedCrossRefGoogle Scholar
  64. 64.
    Nousari HC, Provost TT (2003) Sjögren syndrome. In: Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI (eds) Fitzpatrick's dermatology in general medicine. McGraw-Hill, New YorkGoogle Scholar
  65. 65.
    Ochi Y, DeGroot LJ (1969) Vitiligo in Graves' disease. Ann Intern Med 71:935–940PubMedGoogle Scholar
  66. 66.
    Ongenae K, van Geel N, Naeyaert JM (2003) Evidence for an autoimmune pathogenesis of vitiligo. Pigment Cell Res 16:90–100PubMedCrossRefGoogle Scholar
  67. 67.
    Padula A, Ciancio G, La Civita L et al (2001) Association between vitiligo and spondyloarthritis. J Rheumatol 28:313–314PubMedGoogle Scholar
  68. 68.
    Prignano F, Betts CM, Lotti T (2008) Vogt-Koyanagi-Harada disease and vitiligo. Where does the illness begin? J Electron Microsc 57:25–31Google Scholar
  69. 69.
    Prinz JC (2005) Psoriasis vulgaris and arthropathica. In: Hertl M (ed) Autoimmune diseases of the skin. Springer, New YorkGoogle Scholar
  70. 70.
    Rahman A, Isenberg DA (2008) Sytemic lupus erythemato-sus. N Engl J Med 358:929–939PubMedCrossRefGoogle Scholar
  71. 71.
    Read RW (2002) Vogt-Koyanagi-Harada disease. Ophthalmol Clin North Am 15:333–341PubMedCrossRefGoogle Scholar
  72. 72.
    Rezaei N, Gavalas NG, Weetman AP et al (2007) Autoimmunity as an aetiological factor in vitiligo. J Eur Acad Dermatol Venereol 21:865–876PubMedCrossRefGoogle Scholar
  73. 73.
    Rudwaleit M, Baeten D (2006) Ankylosing spondylitis and bowel disease. Best Pract Res Clin Rheumatol 20:451–471PubMedCrossRefGoogle Scholar
  74. 74.
    Sacher M, Blümel P, Thaler H et al (1990) Chronic active hepatitis associated with vitiligo, nail dystrophy, alopecia and a new variant of LKM antibodies. J Hepatol 10:364–369PubMedCrossRefGoogle Scholar
  75. 75.
    Sandhu K, Kaur I, Kumar B (2004) Psoriasis and vitiligo. J Am Acad Dermatol 51:149–150PubMedCrossRefGoogle Scholar
  76. 76.
    Sardana K, Sharma RC, Koranne RV et al (2002) An interesting case of colocalization of segmental lichen planus and vitiligo in a 14-year-old boy. Int J Dermatol 41:508–509PubMedCrossRefGoogle Scholar
  77. 77.
    Schallreuter KU, Lemke R, Brandt O et al (1994) Vitiligo and other diseases: coexistence or true association? Hamburg study on 321 patients. Dermatology 188:269–275PubMedCrossRefGoogle Scholar
  78. 78.
    Schallreuter KU, Levening C, Berger J (1991) Vitiligo and cutaneous melanoma. Dermatologica 183:239–241PubMedCrossRefGoogle Scholar
  79. 79.
    Sehgal VN, Rege VL, Desai SC (1976) Vitiligo and myas-thenia gravis. Ind J Dermatol Vener Leprol 42:1–2Google Scholar
  80. 80.
    Sharma VK, Dawn G, Kumar B (1996) Profile of alopecia areata in Northern India. Int J Dermatol 35:22–27PubMedCrossRefGoogle Scholar
  81. 81.
    Sharma VK, Kumar B, Dawn G (1996) A clinical study of childhood alopecia areata in Chandigarh, India. Pediatr Dermatol 13:372–377PubMedCrossRefGoogle Scholar
  82. 82.
    Smith DI, Heffernan MP (2008) Vitiligo after the resolution of psoriatic plaques during treatment with adalimumab. J Am Acad Dermatol 58(Suppl):S50–S52PubMedCrossRefGoogle Scholar
  83. 83.
    Soter NA, Kaplan AP (2003)Urticaria and angioedema. In: Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI (eds) Fitzpatrick's dermatology in general medicine. McGraw-Hill, New YorkGoogle Scholar
  84. 84.
    Spritz RA (2007) The genetics of generalized vitiligo and associated autoimmune diseases. Pigment Cell Res 20:271–278PubMedCrossRefGoogle Scholar
  85. 85.
    Stenson WF, Korzenik J (2003) Inflammatory bowel disease. In: Yamada T, Alpers DH, Kaplowitz N, laine L, Owyang C, Powell DW (eds) Textbook of gastroenterol-ogy. Lippincott Williams & Wilkins, PhiladelphiaGoogle Scholar
  86. 86.
    Sukavatcharin S, Tsai JH, Rao NA (2007) Vogt-Koyanagi-Harada disease in Hispanic patients. Int Ophthalmol 27:143–148PubMedCrossRefGoogle Scholar
  87. 87.
    Tan E, Tay YK, Goh CL et al (2002) The pattern and profile of alopecia areata in Singapore—a study of 219 Asians. Int J Dermatol 41:748–753PubMedCrossRefGoogle Scholar
  88. 88.
    Tan RS (1974) Ulcerative colitis, myasthenia gravis, atypical lichen planus, alopecia areata, vitiligo. Proc R Soc Med 67:195–196PubMedGoogle Scholar
  89. 89.
    Terunuma A, Watabe A, Kato T et al (2000) Coexistence of vitiligo and sarcoidosis in a patient with circulating autoan-tibodies. Int J Dermatol 39:551–553PubMedCrossRefGoogle Scholar
  90. 90.
    Toh B-H, Van Driel IR, Gleeson PA (1997) Pernicious anemia. N Engl J Med 337:1441–1448PubMedCrossRefGoogle Scholar
  91. 91.
    Topaktas S, Dener S, Kenis M et al (1993) Myasthenia gravis and vitiligo. Muscle Nerve 16:566–567PubMedGoogle Scholar
  92. 92.
    Tsuruta D, Hamada T, Teramae H et al (2001) Inflammatory vitiligo in Vogt-Koyanagi-Harada disease. J Am Acad Dermatol 44:129–131PubMedCrossRefGoogle Scholar
  93. 93.
    Tugal-Tutkun I, Ozyazgan Y, Akova YA et al (2007) The spectrum of Vogt-Koyanagi-Harada disease in Turkey. Int Ophthalmol 27:117–123PubMedCrossRefGoogle Scholar
  94. 94.
    Ujiie H, Sawamura D, Shimizu H (2006) Development of lichen planus and psoriasis on lesions of vitiligo vulgaris. Clin Exp Dermatol 31:375–377PubMedCrossRefGoogle Scholar
  95. 95.
    Varga J (2008) Systemic sclerosis (scleroderma) and related disorders. In: Fauci AS, Braunwald E, Kasper DL, Hauser SL, Longo DL, Jameson L, Loscalzo J (eds) Harrison's principles of internal medicine. McGraw-Hill, New YorkGoogle Scholar
  96. 96.
    Willer CJ, Ebers GC (2000) Susceptibility to multiple sclerosis: interplay between genes and environment. Curr Opin Neurol 13:241–247PubMedCrossRefGoogle Scholar
  97. 97.
    Winchester R (2003) Psoriatic arthritis. In: Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI (eds) Fitzpatrick's dermatology in general medicine. McGraw-Hill. New YorkGoogle Scholar
  98. 98.
    Yang P, Ren Y, Li B et al (2007) Clinical characteristics of Vogt-Koyanagi-Harada syndrome in Chinese patients. Ophthalmology 114:606–614PubMedCrossRefGoogle Scholar
  99. 99.
    Yu BD, Eisen AZ (2003) Scleroderma. In: Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI (eds) Fitzpatrick's dermatology in general medicine. McGraw-Hill, New YorkGoogle Scholar
  100. 100.
    Zelissen PMJ, Bast EJEG, Croughs RJM (1995) Associated autoimmunity in Addison's disease. J Autoimmunity 8:121–130CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2010

Authors and Affiliations

  1. 1.Department of DermatologyGhent University HospitalGhentBelgium

Personalised recommendations